Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effective Dose of Remimazolam for Sedation under Spinal Anesthesia in Lower Extremity Surgery
KCT0006828Phase 4Not yet recruiting
- Sponsor
- Asan Medical Center
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of remimazolam, sponsored by Asan Medical Center. Planned start Feb 2022; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on KCT0006828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0006828.